Skip to main content
  • Advertise
    Want to Advertise with Us?
    Conquer welcomes advertising and sponsorship collaborations with reputable companies offering high-quality products and services to people affected by cancer.
  • Affiliated Brands
    Academy of Oncology Nurse & Patient Navigators
    The Academy of Oncology Nurse & Patient Navigators (AONN+) is the largest national specialty organization dedicated to improving patient care and quality of life by defining, enhancing, and promoting the role of oncology nurse and patient navigators. Our organization of over 8,900 members was founded in May 2009 to provide a network for all professionals involved and interested in patient navigation and survivorship care services to better manage the complexities of the cancer care treatment continuum for their patients. We view our organization as one consisting of “professional patient advocates” and, to that end, we support and serve our members.
    Journal of Oncology Navigation & Survivorship
    The Journal of Oncology Navigation & Survivorship (JONS) promotes reliance on evidence-based practices in navigating patients with cancer and their caregivers through diagnosis, treatment, and survivorship. JONS also seeks to strengthen the role of nurse and patient navigators in cancer care by serving as a platform for these professionals to disseminate original research findings, exchange best practices, and find support for their growing community.
    The Oncology Nurse-APN/PA
    The Oncology Nurse-APN/PA (TON) provides coverage of the wide spectrum of oncology-related events, trends, news, therapeutics, diagnostics, organizations, and legislation that directly affect hematology/oncology nurses and advanced practitioners involved in healthcare delivery and product utilization. The scope and coverage include a unique presentation of news and events that are shaping the care of patients with cancer.
  • Healthcare Providers
  • Contribute

Drugs for Cholangiocarcinoma (Bile Duct Cancer)

Imfinzi (durvalumab)

Drug company: AstraZeneca

AstraZeneca Access 360 offers 2 financial assistance programs for patients using Imfinzi:

Imfinzi Co-Pay Savings Program

AZ&Me Prescription Savings Program

Lytgobi (futibatinib) Tablets

Drug company: Taiho Oncology

Taiho Oncology offers 1 financial assistance program for patients using Lytgobi:

Taiho Oncology Patient Support Program

Pemazyre (pemigatinib) Tablets

Drug company: Incyte

IncyteCARES offers 3 financial assistance programs for patients who have been prescribed Pemazyre:

Pemazyre Savings Program

Pemazyre Patient Assistance Program

Pemazyre Temporary Access Program

Tibsovo (ivosidenib) Tablets

Drug company: Servier Pharmaceuticals

Servier Pharmaceuticals, through ServierOne, offers 2 financial assistance programs for patients using Tibsovo:

Tibsovo Co-Pay Program

Patient Assistance Program

Table. Drugs Prescribed for Cholangiocarcinoma (Bile Duct Cancer)

  • Drug name (generic name)
  • Drug company
  • Indications
  • Patient support services
    Drug name (generic name)
  • Lytgobi (futibatinib) Tablets
  • Drug company
  • Taiho Oncology
  • Indication
  • Treatment of adults with previously treated, unresectable, locally advanced or metastatic intrahepatic cholangiocarcinoma harboring FGFR2 gene fusions or other rearrangements
  • Patient support services
  • Taiho Oncology Patient Support Program
    Drug name (generic name)
  • Tibsovo (ivosidenib) Tablets
  • Drug company
  • Servier Pharmaceuticals
  • Indication
  • Treatment of adults with previously treated locally advanced or metastatic cholangiocarcinoma and IDH1 mutation
  • Patient support services
  • Tibsovo Co-Pay Program

    Patient Assistance Program

Report Broken Links

Have you encountered a problem with a URL (link) on this page not working or displaying an error message?

Help us fix it! Report broken links here.

Report Broken Link